info@seagull-health.com
SeagullHealth
语言:
search

Eltrombopag(Revolade)

Names
艾曲波帕,瑞弗兰
Indicatons
Used to treat thrombocytopenia in patients with immune thrombocytopenia (ITP), chronic hepatitis C, or severe aplastic...
Price:
Manufacturer:
Novartis
Dosage form:
TABLET
Validity period:
24 months

Reminder: The outer packaging is for reference only, please purchase and use under the guidance of a pharmacist. For read by medical and pharmaceutical professionals only.

Revolade(Eltrombopag) Instructions:Uses,Dosage, Side Effects

PROMACTA (eltrombopag) is an oral medication that works by activating the thrombopoietin receptor, leading to increased platelet production. It is available in tablet and oral suspension forms. 

The drug is metabolized extensively and has specific pharmacokinetic properties that require careful dosing adjustments in certain populations, such as those with hepatic impairment or East-Southeast-Asian ancestry. It is designed to help manage low platelet counts in various medical conditions, with a focus on reducing bleeding risks.

Generic name
Eltrombopag(Revolade)
English name
Eltrombopag
Alternative Names
艾曲波帕,瑞弗兰
Drug prices
Indications

Treatment of thrombocytopenia in adults and pediatric patients (≥1 year) with persistent or chronic ITP who have had an insufficient response to corticosteroids, immunoglobulins, or splenectomy.

Treatment of thrombocytopenia in patients with chronic hepatitis C to enable initiation and maintenance of interferon-based therapy.

First-line treatment of severe aplastic anemia in combination with immunosuppressive therapy (IST) in adults and pediatric patients (≥2 years).

Treatment of severe aplastic anemia in patients with an insufficient response to immunosuppressive therapy.

Therapeutic Target
Thrombopoietin (TPO) receptor
Active Ingredients
Eltrombopag
Dosage Form
TABLET
Specifications
25mg * 28 tablets/box
Dosage and Administration

Administer orally once daily on an empty stomach or with a low-calcium meal (≤50 mg calcium). Avoid concurrent use with polyvalent cation-containing products (e.g., antacids, dairy) within 2 hours before or 4 hours after dosing.

Dosing is individualized based on indication, age, hepatic function, and ethnicity (e.g., reduced initial doses for East/Southeast Asian patients or those with hepatic impairment).

Monitor platelet counts regularly and adjust dose to achieve target platelet levels (e.g., ≥50×10⁹/L for ITP). Maximum daily doses: 75 mg (ITP), 100 mg (hepatitis C), 150 mg (SAA).

Oral suspension must be reconstituted with water and administered immediately (within 30 minutes).

    Recommended articles
    Related articles
    How Effective Is Eltrombopag (Revolade) in Treatment?
    Eltrombopag (Revolade) is an oral thrombopoietin receptor agonist that plays an important role in the treatment of various hematological diseases.How Effective Is Eltrombopag (Revolade) in Treatment?E...
    What Are the Side Effects of Eltrombopag (Revolade)
    Eltrombopag (Revolade) is a thrombopoietin receptor agonist used to treat specific types of thrombocytopenia and aplastic anemia. Although it has good efficacy, potential side effects and precautions ...
    Indications for Eltrombopag (Revolade)
    Eltrombopag (Revolade) is a thrombopoietin receptor agonist developed by GlaxoSmithKline, mainly used to treat thrombocytopenia caused by various reasons.Indications for Eltrombopag (Revolade)Chronic ...
    How to Use Eltrombopag (Revolade)
    Eltrombopag (Revolade) is a thrombopoietin receptor agonist, primarily used clinically for the treatment of chronic immune thrombocytopenia (ITP), chronic hepatitis C-associated thrombocytopenia, and ...
    Precautions for Eltrombopag (Revolade) Use
    Eltrombopag (Revolade) is a thrombopoietin receptor agonist used to treat chronic immune thrombocytopenia (ITP), chronic hepatitis C-associated thrombocytopenia, and severe aplastic anemia. It increas...
    New Drugs
    Infigratinib(Truseltiq)
    Infigratinib(Truseltiq)
    Treatment of previously treated, unresectable locally advanced or metastatic...
    Opicapone(Ongentys)
    Opicapone(Ongentys)
    Adjunctive treatment to levodopa/carbidopa for reducing "off" episodes in...
    Deflazacort(Emflaza)
    Deflazacort(Emflaza)
    Treatment of Duchenne muscular dystrophy (DMD) in patients aged 2 years and...
    Faricimab-svoa(Vabysmo)
    Faricimab-svoa(Vabysmo)
    Treatment of neovascular age-related macular degeneration, diabetic macular...
    Counselling Service
    Global Drug Search
    Clinical Research Recruitment
    Overseas Medical Treatment
    Remote Consultations
    Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
    Submit
    Business
    • Core products
    • Antitumor drugs
    • General drug
    • Antiviral drugs
    • Biological agents
    Contact Us 
    • mailbox:info@lucius.la
    Welcome to consult
    ucius Pharmaceuticals (Lao) Co.,Ltd All rights reserved